U.S. federal health agencies on Tuesday recommended pausing the use ofJohnson&Johnson’s (J&J) single-dose COVID-19vaccineaftersix recipients developed a rare disorder involving blood clots.
TheU.S. Centers for Disease Control and Prevention will hold an advisory meeting on Wednesday to review thecases.
All the six recipients were women between the ages of 18 and 48. One woman died and a second in Nebraska has been hospitalized in critical condition, the New York Times reported, citing officials.
The CDC and theU.S. Food and Drug Administration said in a joint statement that the adverse events appear to be extremely rare right now.
As of April 12, more than 6.8 mil…
Keep on reading: US calls for pause on J&J’s COVID-19 jab after blood clotting cases